China Jo-Jo Drugstores – Initial Interview

China Jo-Jo Drugstores, Inc. (CJJD – $2.65) operates 22 retail pharmacy stores in China offering both western and traditional Chinese medicine. Additionally, the Company provides access to licensed physicians providing consultations and/or outpatient services. China Jo-Jo Drugstores was listed on the OTCBB in September of 2009 and reported its second quarter results a couple of weeks ago. Net sales for […]

Read more

Legal Troubles At Hemispherx

Now that we finally started to see some light at the end of the New Drug Application (NDA) tunnel for Hemispherx Biopharma (HEB – $1.00) , they seem to have sailed into murky legal waters. Since its November 2 press release, in which the Company gave an update on its NDA for Ampligen, several law firms have filed a class […]

Read more

New BUY Recommendation: DAC Technologies Group Int’l

The five stocks that we recommended in 2009 have done very well so far. At today’s closing prices, our five recommendations: Hemispherx Biopharma (HEB), Orsus Xelent (ORS), Boots & Coots (WEL), Acme United (ACU) and Global Green Solutions (GGRN) are up between 30 and 370 percent, or +127% on average. Obviously, it’s impossible to predict if our following recommendations will […]

Read more

Global Green Solutions’ Aera Project Picked Up In Major Newspaper

The Bakersfield Californian, one of California’s leading newspapers, published a very interesting article about two multimillion-dollar renewable energy projects being developed in Kern County, California, USA. One of these projects is the Global Green Solutions’ (GGRN – $0.14) Greensteam project at Aera Energy, one of California’s largest oil and gas producers. If you haven’t read the article yet, we strongly […]

Read more

Hemispherx Biopharma’s Influenza Results

It’s very unfortunate Dr. Hasegawa wasn’t able to attend the Annual Conference of the Japanese Society For Vaccinology held in Sapporo, Japan on September 27, 2009. Although an abstract was published on the Hemispherx website, we feel as if the investment community only glanced over the presentation. To help us clarify the abstract, we had a conference call this week […]

Read more

Hemispherx Expands Its Manufacturing Facilities

We also received positive news from our biotech stock Hemispherx Biopharma (HEB – $2.05). The Company will spend up to $4.4 million for engineering studies, capital improvements, system upgrades, and introduction of building management systems to enhance production for Alferon N and its two experimental therapeutics Alferon LDO and Ampligen. These investments will bring the capacity of Hemispherx’ manufacturing site […]

Read more

Boots & Coots Buys Halliburton Business And News On Big Potential Contract

Furthermore Boots & Coots (WEL – $1.68) announced it acquired the external abrasive jet cutting systems from Halliburton Company. The abrasive jet cutting system was developed by Halliburton in 1991 to assist firefighting crews in Kuwait battle more than seven hundred fires left after the Iraq invasion. The external abrasive jet cutter is designed to be easily positioned on a […]

Read more

Hemispherx Biopharma Cancels Stockholders’ Meeting

Hemispherx Biopharma (HEB – $2.03) announced on Wednesday it cancelled its adjourned stockholders’ meeting. The reason was very simple, the Company obtained insufficient votes to pass proposal no. 3. With this proposal being the sole purpose of the adjourned stockholders’ meeting, there was no need to hold the meeting. In proposal 3, shareholders were asked if HEB could increase the […]

Read more
1 3 4 5 6 7 8